Long term pain relief better with rESWT versus corticosteroid injection for carpal tunnel syndrome .
This report has been verified
by one or more authors of the
original publication.
Comparison of single-dose radial extracorporeal shock wave and local corticosteroid injection for treatment of carpal tunnel syndrome including mid-term efficacy: a prospective randomized controlled trial
BMC Musculoskelet Disord. 2018 Jan 25;19(1):3225 patients with carpal tunnel syndrome were randomized to treatment with either a single session of radial extracorporeal shockwave therapy or a single corticosteroid injection. Primary outcome was the Boston Carpal Tunnel Questionnaire, including both the Symptoms and Functional scores. Patients were assessed at 1, 4, 12, and 24 weeks after treatment. Within-group reductions from baseline in BCTQ scores were significant from 4 weeks to 24 weeks in the rESWT group, in contrast to only 1 week to 4 weeks in the corticosteroid injection group. The reduction in scores from 12 weeks to 24 weeks were significantly greater in the rESWT compared to the corticosteroid injection for each of the BCTQ total score, Symptoms subscore, and Functional subscore.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
